About
Cancer Immunotherapies
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
83
By Phase
PHASE1/PHASE2: 1
By Status
RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05290662Lead Sponsor
Registry of Patients Having Received oNKord®
N/ARecruiting
50 participants
Started: Jun 14, 2022 · Completed: Mar 31, 2028
NCT04632316Lead Sponsor
A Trial to Evaluate the Safety and Efficacy of oNKord® in Subjects With Acute Myeloid Leukemia
PHASE1/PHASE2Unknown
33 participants
Started: Dec 8, 2020 · Completed: Apr 30, 2023
Locations (1)
Headquarters
Nijmegen, Netherlands
Map
Loading map...